Terms: = Kidney tumors AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
3 results:
1. Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.
Zheng W; Jiang W; Wu Q; Chen J; Zhang Z; Yu S; Guo C
BMJ Open; 2023 Apr; 13(4):e068044. PubMed ID: 37185648
[TBL] [Abstract] [Full Text] [Related]
2. Renal neoplasia with papillary architecture involving the pelvicalyceal system.
Gupta S; Cheville JC; Galeano BK; Sukov WR; Herrera-Hernandez L; Reed KA; Lohse CM; Thompson RH; Boorjian SA; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Jan; 107():46-57. PubMed ID: 33166576
[TBL] [Abstract] [Full Text] [Related]
3. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a braf-positive follicular variant of papillary thyroid cancer.
Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
[TBL] [Abstract] [Full Text] [Related]